Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy

Cell Reports(2023)10.1016/j.celrep.2023.113016Source: DataRank Database

Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy is a research paper published in Cell Reports (2023). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

geo nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)OA: goldTopics (28)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Kai Kang ORCID,Kwok Peng Ng ORCID,Tomas Radivoyevitch ORCID,Kurt A. Schalper ORCID,Zhang Hua ORCID

Live enrichment

PubMed:37597186 PMC:PMC10528072

National Institutes of Health

Grant: S10OD018205

National Heart, Lung, and Blood Institute

Grant: PO1 HL146372

National Cancer Institute

Grant: P30 CA043703

National Cancer Institute

Grant: R21 CA263430

National Cancer Institute

Grant: RO1 CA204373

NHLBI NIH HHS

Grant: U01 HL117658

NHLBI NIH HHS

Grant: P01 HL146372

NCI NIH HHS

Grant: R01 CA138858

NCI NIH HHS

Grant: R01 CA204373

NHLBI NIH HHS

Grant: R44 HL135896

NCATS NIH HHS

Grant: UL1 TR001863

National Institutes of Health

Grant: 3P30CA043703-20S1

Case Comprehensive Cancer Center Support Grant

National Institutes of Health

Grant: 5R21CA263430-02

Operationalizing DNMT1-Targeting to Treat Chemorefractory Pancreatic Cancer

National Institutes of Health

Grant: 1R01CA204373-01

Imaging Liver Cancer Proliferation

National Institutes of Health

Grant: 1S10OD018205-01A1

PerkinElmer IVIS Spectrum CT

National Institutes of Health

Grant: 5P01HL146372-04

Targeting Enzymatic Regulation of Fetal Hemoglobin Repression

goldLicense: cc-by-nc-nd

publisherhttp://www.cell.com/article/S2211124723010276/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124723010276?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124723010276?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10528072/pdf/nihms-1928302.pdf

repositoryhttps://doaj.org/article/6e798291ce2a49cb8119368cddc4ce46

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsMiceLung NeoplasmsCell CycleCell DivisionTumor Suppressor Protein p53Small Cell Lung Carcinoma

Keywords

5-azacytidineradiation resistancesmall cell lung cancerDecitabineChemotherapy ResistanceImmune Checkpoint BlockadePyrimidine MetabolismTetrahydrouridineCp: CancerMiceLung NeoplasmsQH301-705.5Cell CycleAnimalsBiology (General)Tumor Suppressor Protein p53Small Cell Lung CarcinomaArticleCell Division

Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy

FAIR Checklist

Authors (14)

Funding (16 grants)

Open Access

Topics

Annotations (Europe PMC)